InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
IMVT
Result 179 decisions over 120 months
Reset filters
Direction ?
Both214 Bought35 Sold179
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: IMVT Direction: Sold
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
IMVT Immunovant, Inc.
28 Aug 2026
Pande Atul
Director
Sold on a plan
1,500
$64.91K
1.3%
IMVT Immunovant, Inc.
20 Aug 2026
Gloria Melanie
Chief Operating Officer
Sold at will
3,056
$134.95K
1.4%
IMVT Immunovant, Inc.
24 Jul 2026
Pande Atul
Director
Sold on a plan
1,500
$59.70K
1.3%
IMVT Immunovant, Inc.
23 Jul 2026
Girao Tiago
Chief Financial Officer
Sold at will
6,798
$263.01K
2.7%
IMVT Immunovant, Inc.
23 Jul 2026
Stout Jay S
Chief Technology Officer
Sold at will
2,857
$110.54K
1.4%
IMVT Immunovant, Inc.
8 Jul 2026
Stout Jay S
Chief Technology Officer
Sold at will 4×
3,487
$137.92K
1.6%
IMVT Immunovant, Inc.
8 Jul 2026
Gloria Melanie
Chief Operating Officer
Sold at will 2×
2,036
$80.53K
0.9%
IMVT Immunovant, Inc.
8 Jul 2026
Van Tuyl Christopher
Chief Legal Officer
Sold at will 2×
1,206
$47.70K
0.7%
IMVT Immunovant, Inc.
2 Jul 2026
Venker Eric
Chief Executive Officer
Sold at will
3,092
$118.98K
1.2%
IMVT Immunovant, Inc.
26 Jun 2026
Stout Jay S
Chief Technology Officer
Sold at will 2×
40,000
$1.53M
15.9%
IMVT Immunovant, Inc.
26 Jun 2026
Van Tuyl Christopher
Chief Legal Officer
Sold at will 2×
17,824
$682.89K
9.0%
IMVT Immunovant, Inc.
26 Jun 2026
Gloria Melanie
Chief Operating Officer
Sold at will 2×
17,714
$678.60K
7.3%
IMVT Immunovant, Inc.
26 Jun 2026
Girao Tiago
Chief Financial Officer
Sold at will
10,000
$384.60K
3.9%
IMVT Immunovant, Inc.
26 Jun 2026
Pande Atul
Director
Sold on a plan
1,500
$57.02K
1.3%
IMVT Immunovant, Inc.
18 Jun 2026
Van Tuyl Christopher
Chief Legal Officer
Sold at will
2,634
$93.22K
1.4%
IMVT Immunovant, Inc.
15 Jun 2026
Pande Atul
Director
Sold on a plan
1,500
$51.03K
1.3%
IMVT Immunovant, Inc.
28 May 2026
Fromkin Andrew J.
Director
Sold at will 2×
221,951
$7.44M
74.9%
IMVT Immunovant, Inc.
20 May 2026
Pande Atul
Director
Sold on a plan
6,000
$192.00K
4.9%
IMVT Immunovant, Inc.
20 May 2026
Gloria Melanie
Chief Operating Officer
Sold at will 3×
3,115
$101.07K
1.3%
IMVT Immunovant, Inc.
1 May 2026
Susman Robert Graham
Director
Sold on a plan
2,502
$67.98K
6.4%
IMVT Immunovant, Inc.
23 Apr 2026
Girao Tiago
Chief Financial Officer
Sold at will
25,760
$763.01K
9.4%
IMVT Immunovant, Inc.
23 Apr 2026
Stout Jay S
Chief Technology Officer
Sold at will
2,754
$81.57K
1.1%
IMVT Immunovant, Inc.
8 Apr 2026
Stout Jay S
Chief Technology Officer
Sold at will 2×
10,132
$251.58K
3.8%
IMVT Immunovant, Inc.
8 Apr 2026
Gloria Melanie
Chief Operating Officer
Sold at will
8,722
$216.57K
3.4%
IMVT Immunovant, Inc.
8 Apr 2026
Van Tuyl Christopher
Chief Legal Officer
Sold at will
5,165
$128.25K
2.7%
IMVT Immunovant, Inc.
2 Apr 2026
Venker Eric
Chief Executive Officer
Sold at will 2×
14,229
$342.85K
42.1%
IMVT Immunovant, Inc.
18 Mar 2026
Van Tuyl Christopher
Chief Legal Officer
Sold at will
2,877
$71.84K
1.9%
IMVT Immunovant, Inc.
25 Feb 2026
Gloria Melanie
Chief Operating Officer
Sold at will 3×
3,238
$90.18K
1.9%
IMVT Immunovant, Inc.
21 Jan 2026
Stout Jay S
Chief Technology Officer
Sold at will
1,977
$51.46K
1.0%
IMVT Immunovant, Inc.
7 Jan 2026
Stout Jay S
Chief Technology Officer
Sold at will 2×
1,203
$31.91K
0.6%
IMVT Immunovant, Inc.
18 Dec 2025
Van Tuyl Christopher
Chief Legal Officer
Sold at will 2×
10,813
$290.94K
6.7%
IMVT Immunovant, Inc.
1 Dec 2025
Fromkin Andrew J.
Director
Sold on a plan 2×
22,249
$517.19K
20.6%
IMVT Immunovant, Inc.
1 Dec 2025
Hughes Douglas J.
Director
Sold on a plan 2×
15,000
$348.67K
11.0%
IMVT Immunovant, Inc.
20 Nov 2025
Gloria Melanie
Chief Operating Officer
Sold at will 2×
12,626
$298.24K
6.8%
IMVT Immunovant, Inc.
22 Oct 2025
Geffner Michael
Chief Medical Officer
Sold at will
2,595
$49.38K
1.2%
IMVT Immunovant, Inc.
22 Oct 2025
Stout Jay S
Chief Technology Officer
Sold at will
2,520
$47.96K
1.2%
IMVT Immunovant, Inc.
8 Oct 2025
Stout Jay S
Chief Technology Officer
Sold at will
1,585
$25.84K
0.8%
IMVT Immunovant, Inc.
8 Oct 2025
Geffner Michael
Chief Medical Officer
Sold at will
1,272
$20.73K
0.6%
IMVT Immunovant, Inc.
23 Jul 2025
Stout Jay S
Chief Technology Officer
Sold at will
2,805
$50.91K
1.4%
IMVT Immunovant, Inc.
23 Jul 2025
Geffner Michael
Chief Medical Officer
Sold at will
2,385
$43.29K
1.1%
IMVT Immunovant, Inc.
9 Jul 2025
Stout Jay S
Chief Technology Officer
Sold at will
1,519
$26.19K
0.7%
IMVT Immunovant, Inc.
9 Jul 2025
Geffner Michael
Chief Medical Officer
Sold at will
1,160
$20.00K
0.5%
IMVT Immunovant, Inc.
23 Apr 2025
Geffner Michael
Chief Medical Officer
Sold at will
2,349
$34.74K
1.0%
IMVT Immunovant, Inc.
23 Apr 2025
Stout Jay S
Chief Technology Officer
Sold at will
1,925
$28.47K
0.9%
IMVT Immunovant, Inc.
16 Apr 2025
Salzmann Peter
Chief Executive Officer
Sold at will
8,321
$123.90K
0.7%
IMVT Immunovant, Inc.
16 Apr 2025
Barnett Eva Renee
Chief Financial Officer
Sold at will
2,993
$44.57K
0.7%
IMVT Immunovant, Inc.
9 Apr 2025
Salzmann Peter
Chief Executive Officer
Sold at will
28,094
$364.94K
2.3%
IMVT Immunovant, Inc.
9 Apr 2025
Barnett Eva Renee
Chief Financial Officer
Sold at will 2×
11,063
$143.71K
2.7%
IMVT Immunovant, Inc.
9 Apr 2025
Geffner Michael
Chief Medical Officer
Sold at will
6,169
$80.14K
2.6%
IMVT Immunovant, Inc.
9 Apr 2025
Stout Jay S
Chief Technology Officer
Sold at will
5,004
$65.00K
2.3%
Showing 1–50 of 179. Page 1 of 4 Older →